Single Dose of Chemotherapy may Tackle Testicular Cancer

by Rajashri on  October 6, 2008 at 3:48 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

 Single Dose of Chemotherapy may Tackle Testicular Cancer
A study by the Medical Research Council has found that a single dose of chemotherapy may be enough to tackle testicular cancer.

The study involved 1,500 patients, among whom 904 were given radiotherapy, and 573 were assigned to receive carboplatin. Dr Ben Mead of the Southampton University said that although the relapse rate was similar in both groups, people who were given injections were able to return to normal lives sooner than the radiotherapy group.

"Giving patients a carboplatin injection rather than radiotherapy is less unpleasant with fewer long-term risks," he added. "The initial results of the trial looked encouraging, but we needed to follow patients for another four years before we knew for sure that they had been cured."

The results of the study will be presented Monday at a cancer conference in Birmingham.

Source: Medindia
RAS/SK

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Cancer and Homeopathy Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Chemotherapy Chemotherapy Drugs Cancer Facts Cancer Testicular Cancer Peritoneal Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive